Research is at the
Heart of Our Innovation
At Vickro Biopharma, we invest in advanced technologies and scientific capabilities to develop high-quality biologics, probiotics, enzymes, postbiotics, LBPs and fermentation-derived actives.
Our research integrates directed evolution, protein engineering, CRISPR-Cas gene editing and synthetic biology to build novel proteins, engineered microbial strains and next-generation expression platforms.
Advancing global biomanufacturing
Technology Focus
Next-Gen Expression Platforms
Our R&D Strategy
Driven by a highly skilled in-house scientific team focused on continuous innovation and value creation.
Sustainable Bioprocesses
Develop sustainable, environmentally aligned bioprocesses that minimize waste and maximize efficiency.
Portfolio Enhancement
Enhance our existing product portfolio with improved performance, stability and efficacy profiles.
High-Value Creation
Create new high-value biologics, microbial strains, enzymes & actives targeting unmet market needs.
Scalable Manufacturing
Translate early scientific ideas into robust, scalable manufacturing processes ready for commercial production.
Global Compliance
Maintain rigorous global regulatory and quality compliance standards throughout the development lifecycle.
Our strategy ensures long-term competitiveness and scientific excellence